 Oral contraceptives reproductive system cancer Benefits risks Large epidemiologic studies date United significant increase overall incidence breast cancer women oral contraceptives OCs cumulative risk breast cancer women years age OC use incidence breast cancer certain subgroups premenopausal women OCs warrants Evidence latency period development breast cancer OC users Studies date risk invasive cervical cancer OC use data cervical intraepithelial neoplasia inconclusive fraught variables unequivocal evidence OC use incidence reproductive system cancers ovarian endometrial